Pharvaris (PHVS) reported a Q2 net loss Wednesday of 0.70 euro ($0.81) per diluted share, narrowing from a loss of 0.83 euro per share a year earlier.
Analysts polled by FactSet expected a loss of 0.66 euro per share.
No revenue was reported for the period.